ASHM’s Decision Making in Hepatitis B tool has been updated to align with the Australian consensus recommendations for the management of hepatitis B infection (2022) and B Positive.
ASHM’s Decision Making in Hepatitis B tool has been updated to align with the Australian consensus recommendations for the management of hepatitis B infection (2022) and B Positive.
Presenting a clear and simple step-by-step for primary care providers to follow, our 2-page Decision Making in Hepatitis B tool provides a clear and comprehensive overview to take you through the diagnosis and management of hepatitis B from start to finish.
This resource supports clinical decision-making in hepatitis B, including who to test, how to test and interpret serology, how to conduct an initial assessment, and how to conduct ongoing monitoring. It also provides an overview of the natural history of chronic hepatitis B, which can be used when making decisions about management and treatment, including when to refer to a hepatitis B s100 community prescriber or specialist
Updates to this edition of the resource include:
- Changes to nomenclature for the four phases of the disease, to reflect the understanding of the natural history of hepatitis B more accurately
- Priority populations for HCC surveillance
Access the resource here.
